VCEL
Vericel Corp Ord
NASDAQ: VCEL · HEALTHCARE · BIOTECHNOLOGY
$41.09
-5.04% today
Updated 2026-10-28
Market cap
$2.22B
P/E ratio
92.06
P/S ratio
7.23x
EPS (TTM)
$0.47
Dividend yield
—
52W range
$29 – $49
Volume
0.5M
Vericel Corp Ord (VCEL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$41.09
12-Month target
$11.85
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 7.91%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.